Accredited Educational Activities

The Art of Ophthalmology Medicine: Individualizing Therapy in Diabetic Macular Edema in an Era of Expanded Treatment Options

This enduring activity focuses on individualizing therapy for the treatment of diabetic macular edema (DME). Providers will learn about the safety, efficacy, and durability of established and emerging DME therapies, as well as technological updates that can be used to facilitate patient screening, monitoring, and treatment interval decision-making. This activity uses a unique documentary approach to share a patient story along with commentary from a retinal disease expert.

The RELIEF Initiative: Seeing the Future: Next-Generation Treatment Approaches for DR, AMD and RVO

This enduring activity focuses on the use of next-generation therapies such as gene therapy, biosimilars, advanced delivery systems, artificial intelligence, and advancements in pharmacological treatments, including new molecular targets and therapeutic formulations for the management of patients with diabetic retinopathy, age-related macular degeneration, and retinal vein occlusion. Listen to a retina expert explain the rationale behind these new therapies, as well as the clinical trial data regarding their safety, efficacy, and mechanisms of action to expand treatment options and potentially improve visual outcomes in patients with retinal vascular conditions.

Seeing Eye to Eye: An Ophthalmology-Primary Care Collaboration Emphasizing the Importance of Screening and Early Diagnosis of Retinopathy in Patients with Diabetes

This clinical conversations exchange enduring focuses on timely screening and identification of diabetic retinopathy (DR) and/or diabetic macular edema (DME) and the impact that timely treatment as well as team-based approaches can have on vision. Engage with expert discussion from both ophthalmology and primary care perspectives to learn more about the benefits of early detection and intervention, the role of vascular endothelial growth factor (VEGF) in the development of retinopathy, and multidisciplinary management strategies focusing on ocular as well as systemic risk factor interventions that can help individualize care and promote healthy vision in diabetes.

The RELIEF Initiative
Screening Out Retinopathy: Pathways to Improving Diagnosis and Management in Patients with Diabetes

This TeleECHO Smart Reach Replay enduring focuses on timely screening and identification of diabetic retinopathy (DR) and/or diabetic macular edema (DME) and the impact that treatment timing can have on vision. Learn more about the benefits of early detection and intervention, treatment strategies, and ways to leverage technology/teleophthalmology to overcome screening barriers, enhancing healthy vision in diabetes.

IMMERSIVE SIMULATION EXPERIENCE

Vision RELIEF: Navigating Anti-VEGF Treatment Options to Optimize Treatment Individualization

This Immersive Simulation Experience in diabetic retinopathy (DR), neovascular age-related macular degeneration (nAMD) and retinal vein occlusion (RVO) allows learners to engage in clinical decision-making to individualize treatment with anti-vascular endothelial growth factor (anti-VEGF) therapies. By participating in this simulated 3D encounter, you will observe patient-provider interactions and use pertinent information from the patients’ electronic chart to decide the next best course of action at various key points in care, including identifying eyes that may benefit from anti-VEGF treatment, incorporating assessment of efficacy and safety data into treatment decisions, and strategizing changes in treatment approach to achieve optimal outcomes.

New Insights on the Diagnosis and Treatment of Nonproliferative Diabetic Retinopathy

This enduring program targets critical issues in nonproliferative diabetic retinopathy (NPDR), including risk for retinopathy development and progression, how early treatment can help prevent progression to vision-threatening complications, and treatment strategies for NPDR. Learn essential elements of assessment and management, as well as clinical trial data on the latest approaches in care, helping to preserve vision in diabetes.

A Close Look at the Diagnosis and Treatment of Patients with Retinal Vascular Disease

This online activity targets healthcare gaps related to the diagnosis and management of diabetic retinopathy (DR), age-related macular degeneration (AMD), and retinal vein occlusion (RVO), impacting outcomes through risk stratification, diagnostic strategies, and treatment individualization with anti-VEGF agents.

Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Pin It on Pinterest

Directory
Scroll to Top

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Directory